A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

PHASE4CompletedINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Bacterial Conjunctivitis
Interventions
DRUG

gatifloxacin

Day 1-6 = 1 drop of study medication three times a day

DRUG

moxifloxacin 0.5% eye drops

Day 1-6 = 1 drop of study medication three times a day

Trial Locations (2)

Unknown

Sacramento

Whitby

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY